La soledad puede reducir la supervivencia tras un diagnóstico de cáncer, según un estudio
LUNES, 5 de junio de 2023 (HealthDay News) — En Estados Unidos, hay una “epidemia de soledad”, y los sentimientos de aislamiento se han vinculado con la enfermedad cardiaca, el accidente cerebrovascular y otras afecciones de la salud. Ahora, una nuev…
Learn MoreLa soledad puede reducir la supervivencia tras un diagnóstico de cáncer, según un estudio
LUNES, 5 de junio de 2023 (HealthDay News) — En Estados Unidos, hay una “epidemia de soledad”, y los sentimientos de aislamiento se han vinculado con la enfermedad cardiaca, el accidente cerebrovascular y otras afecciones de la salud. Ahora, una nuev…
Learn MoreLoneliness Can Cut Survival After a Cancer Diagnosis: Study
MONDAY, June 5, 2023 (HealthDay News) — There’s a “loneliness epidemic” in the United States, and feelings of isolation have been linked to heart disease, stroke and other health conditions.Now, new research suggests that cancer survivors who feel lo…
Learn MorePTSD, Other Mental Health Ills Haunt Gunshot Survivors
TUESDAY, May 23, 2023 (HealthDay News) — For people who survive gunshot wounds, the trauma may leave mental scars that worsen with time, a new study finds.Among 87 adults treated for gun injuries at a Wisconsin trauma center, many had worsening sympt…
Learn MoreLiving in Disadvantaged Neighborhood Shortens Breast Cancer Survival
THURSDAY, April 27, 2023 (HealthDay News) — Breast cancer-specific survival is shorter in women from disadvantaged neighborhoods versus advantaged neighborhoods, according to a study published online April 21 in JAMA Network Open.Neha Goel, M.D., fro…
Learn MoreAdding Dostarlimab Improves Progression-Free Survival in Endometrial Cancer
TUESDAY, April 4, 2023 (HealthDay News) — For patients with primary advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel increases progression-free survival versus carboplatin-paclitaxel alone, according to a study publis…
Learn MoreDrug Combo Shows Promise Against Advanced Head and Neck Cancer
MONDAY, April 3, 2023 (HealthDay News) — An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says.Ficlatuzumab used in combinatio…
Learn MoreFrequent Social Activity Tied to Longer Survival in Older Adults
THURSDAY, March 9, 2023 (HealthDay News) — More frequent participation in social activity is associated with significantly longer overall survival in older people, according to a study published online March 6 in the Journal of Epidemiology & Communi…
Learn MoreSurvival Rate Lower for Surgery Nine Weeks or More After Breast Cancer Diagnosis
THURSDAY, March 2, 2023 (HealthDay News) — Time from breast cancer diagnosis to surgery of nine weeks or longer is associated with worse overall survival, according to a study published online March 1 in JAMA Surgery.Alyssa A. Wiener, M.D., from the …
Learn MoreSBRT Well Tolerated, Effective for Primary Lung Neuroendocrine Tumor
THURSDAY, Feb. 23, 2023 (HealthDay News) — For patients with primary lung neuroendocrine tumor (LNET), stereotactic body radiotherapy (SBRT) is well tolerated and provides excellent locoregional control, according to a study published online Jan. 25 …
Learn More